Drug Approval | August 31, 2023
Strides receives USFDA approval for Mycophenolate Mofetil for oral suspension
The approval bolsters the company's Mycophenolate Mofetil portfolio
The approval bolsters the company's Mycophenolate Mofetil portfolio
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Subscribe To Our Newsletter & Stay Updated
